Medical Devices Middle East

Middle East Deep Brain Stimulation Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Middle East Deep Brain Stimulation Market Industry Trends and Forecast to 2034: Segmented by (Product, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Middle East · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $61.6 Mn Placeholder estimate
Estimate 2025 $67.8 Mn 4.1% of the global market
Projected 2034 $159.8 Mn 135.8% Adds $92.0 Mn over 9 forecast years
CAGR 2025–2034 10.0% Faster than 52% of 173 Medical Devices markets here
Key players 5
  • Middle East is 4.07% of the global market.
  • Among regions, the largest is North America at $928.7 Mn.
  • Fastest growing: Africa at 10.4% a year.
  • Middle East ranks 5th of 6 by size among regions.

Market size projection

Middle East

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$92.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Deep Brain Stimulation Market market size by year, Middle East
YearMarket sizeChange that yearSince 2025
2024 (estimate) $61.6 Mn — —
2025 (base) $67.8 Mn +$6.2 Mn —
2026 (forecast) $74.5 Mn +$6.8 Mn +10%
2027 (forecast) $82.0 Mn +$7.5 Mn +21%
2028 (forecast) $90.2 Mn +$8.2 Mn +33.1%
2029 (forecast) $99.2 Mn +$9.0 Mn +46.4%
2030 (forecast) $109.1 Mn +$9.9 Mn +61.1%
2031 (forecast) $120.0 Mn +$10.9 Mn +77.2%
2032 (forecast) $132.0 Mn +$12.0 Mn +94.9%
2033 (forecast) $145.2 Mn +$13.2 Mn +114.4%
2034 (forecast) $159.8 Mn +$14.5 Mn +135.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.66 Bn
  2. North America $928.7 Mn
  3. US $608.6 Mn
  4. Europe $331.2 Mn
  5. APAC $317.0 Mn
  6. China $122.4 Mn
  7. Canada $116.2 Mn
  8. Japan $90.9 Mn
  9. Latin America $74.7 Mn
  10. Middle East (this report) $67.8 Mn
  11. Germany $56.4 Mn
  12. France $50.4 Mn
  13. Brazil $41.4 Mn
  14. Italy $39.7 Mn
  15. UK $38.2 Mn
  16. Ecuador $34.5 Mn
  17. Spain $33.4 Mn
  18. India $34.8 Mn
  19. Saudi Arabia $31.9 Mn
  20. Mexico $28.5 Mn
  21. Africa $24.3 Mn
  22. Australia $21.6 Mn
  23. New Zealand $15.7 Mn
  24. Russia $15.2 Mn
  25. South Africa $10.1 Mn
  26. UAE $9.7 Mn
  27. Egypt $4.2 Mn
  28. Philippines $4.0 Mn
  29. Hong Kong $2.7 Mn
  30. Malaysia $2.6 Mn
  31. Thailand $2.3 Mn
  32. Singapore $1.7 Mn
  33. Kenya $1.3 Mn

Report snapshot

Middle East Deep Brain Stimulation Market Analysis at a glance
Market size, 2025$67.8 Mn placeholder estimate
Forecast, 2034$159.8 Mn placeholder estimate
Growth (CAGR), 2025–203410.0% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, indication and end user (see all)
Key playersMedtronic, Boston Scientific Corporation, Abbott Laboratories, Newronika, SceneRay (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Middle East Deep Brain Stimulation Market Analysis Executive Summary

Deep brain stimulation places thin wires in the brain connected to a pacemaker-like device, to treat Parkinson's, tremor and other conditions.

Key segments of the deep Brain Stimulation market include product (Single-Channel, Dual-Channel and Rechargeable) and indication (Parkinson's, Essential Tremor and Dystonia).

Bar chart: Middle East Deep Brain Stimulation market size, 2024–2034, placeholder estimates. $61.6 Mn in 2024, $67.8 Mn in 2025 and $159.8 Mn in 2034, 10.0% CAGR.
Middle East Deep Brain Stimulation market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Middle East Deep Brain Stimulation Market Dynamics

Market Growth Drivers

An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the deep Brain Stimulation market.

Opportunity

Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the deep Brain Stimulation market strong room to grow.

Market Restraints

Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the deep Brain Stimulation market.

Competitive Landscape for Deep Brain Stimulation Market in Middle East

The deep Brain Stimulation market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Deep Brain Stimulation Market in Middle East

Deep Brain Stimulation in Middle East: rules and payment

In some of the countries we cover here, medical devices are regulated by SFDA (Saudi Arabia)⁠[1] and EDE (UAE)⁠[2]. How care is paid for in some of these countries: free public care and CHI-regulated insurance (Saudi Arabia)⁠[3] and mandatory health insurance (UAE)⁠[4].

[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.

[2] Emirates Drug Establishment. Checked 14 Nov 2026.

[3] Council of Health Insurance. Checked 14 Nov 2026.

[4] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how deep Brain Stimulation products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Middle East.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Deep Brain Stimulation right now, from free public sources.

Latest research 7,259 papers since 2021 (worldwide)

  1. Refractory Meige syndrome treated with bilateral globus pallidus internus deep brain stimulation. BMJ case reports, 2026
  2. Computer vision-derived gait-state tracking of acute treatment response in Parkinson's disease: external and prospective validation. NPJ Parkinson's disease, 2026
  3. Rehabilitation Strategies for Focal Hand Dystonia:A Narrative Review with Systematic Approach. The journal of medical investigation : JMI, 2026
  4. Continuous Recording of Local Field Potentials via Deep Brain Stimulation Electrodes in Parkinson's Disease:A Technical and Conceptual Review. The journal of medical investigation : JMI, 2026
  5. Flexible recording electrodes preliminarily reveal the brain-spinal circuit mechanism of spinal cord stimulation in the treatment of motor impairment in the mouse model of Parkinson's disease. Science China. Life sciences, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Deep Brain Stimulation in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Deep Brain Stimulation market in Middle East?
Placeholder estimate: about $67.8 Mn in 2025, rising to about $159.8 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Deep Brain Stimulation market in Middle East growing?
Placeholder estimate: about 10.0% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Deep Brain Stimulation market report cover?
The report splits the market by product (Single-Channel, Dual-Channel, Rechargeable, Adaptive Systems), indication (Parkinson's, Essential Tremor, Dystonia, Epilepsy and more) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Deep Brain Stimulation market?
Key players include Medtronic, Boston Scientific Corporation, Abbott Laboratories, Newronika and SceneRay.
What is driving the Deep Brain Stimulation market?
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the deep Brain Stimulation market.
How much research is published on Deep Brain Stimulation?
PubMed lists 7,259 papers on Deep Brain Stimulation added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Deep Brain Stimulation in Middle East? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Brain Cancer Diagnosis: Imaging and New BiomarkersAbout 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died… Alzheimer's Diagnosis: Blood Tests and Earlier Answers57 million people live with dementia. In May 2025 the US FDA cleared the first blood test used to help… Cannabis-Based Medicines: Science and RegulationThe FDA has approved one cannabis-derived medicine, Epidiolex, for rare epilepsies, and three synthetic…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Middle East

See all
Same topic, other categories

Related on brain and nerves

See the topic